JP Morgan Maintains Overweight on Omada Health, Raises Price Target to $30

Benzinga · 3d ago
JP Morgan analyst Lisa Gill maintains Omada Health (NASDAQ:OMDA) with a Overweight and raises the price target from $26 to $30.